✦ LIBER ✦

Effects of the V1a and V2 Vasopressin receptor antagonist YM087 in hyponatremic patients with chronic heart failure

✍ Scribed by William T. Abraham; D.P. Suresh; Lynne E. Wagoner; Jennifer McCord; Garrie J. Haas; Susan M. Rydzinski; Carrie Nelson; Rebecca G. BakkerArkema

Book ID: 119590184
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 139 KB
Volume: 5
Category: Article
ISSN: 1532-8414
DOI: 10.1016/s1071-9164(99)91536-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic effe

Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2vasopressin receptor antagonist in normal subjects

✍ M. Burnier; A. F. Fricker; D. Hayoz; J. Nussberger; H. R. Brunner 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 110 KB

Cardiovascular and renal effects of coni

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure

✍ Takeyuki Yatsu; Yuichi Tomura; Atsuo Tahara; Koh-ichi Wada; Toshiyuki Kusayama; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Pharmacological characterization of YM08

Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist

✍ A. Tahara; M. Saito; T. Sugimoto; Y. Tomura; K. Wada; T. Kusayama; J. Tsukada; N 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 83 KB

Pharmacological profile of YM087, a nove

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

✍ Takeyuki Yatsu; Yuichi Tomura; Atsuo Tahara; Koh-ichi Wada; Junko Tsukada; Watar 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Molecular modeling of interactions of th

Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors.

✍ Artur Giełdoń; Rajmund Kaźmierkiewicz; Rafał Ślusarz; Jerzy Ciarkowski 📂 Article 📅 2001 🏛 Springer Netherlands 🌐 English ⚖ 922 KB

Acute hemodynamic effects of conivaptan,

Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure

✍ J.E. Udelson; W.B. Smith; G.H. Hendrix 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB